Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $275.0000 (-0.9%) ($247.5000 - $275.0000) on Wed. Jan. 25, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.29% (three month average) | RSI | 51 | Latest Price | $275.0000(-0.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.8% a day on average for past five trading days. | Weekly Trend | CAPR declines -2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(4%) PEJ(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -2.145% in a week (0% probabilities). IGOV(-2%) REMX(-1%) EWY(-1%) XLU(0%) XLP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.145% (StdDev 4.29%) | Hourly BBV | 0 () | Intraday Trend | 11.1% | | | |
|
5 Day Moving Average | $260.7(5.49%) | 10 Day Moving Average | $260.33(5.64%) | 20 Day Moving Average | $264.43(4%) | To recent high | -11.3% | To recent low | 14.6% | Market Cap | $5.417b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |